Respiratory and Blood Stream Infections are Associated with Subsequent Venous Thromboembolism After Primary Intracerebral Hemorrhage.
Anticoagulants
Complications
Infection
Inflammation
Intracranial hemorrhage
Risk factors
Thrombosis
Venous thromboembolism
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
10
5
2020
medline:
30
9
2021
entrez:
10
5
2020
Statut:
ppublish
Résumé
Infection and venous thromboembolism (VTE) are associated with worse outcomes after intracerebral hemorrhage (ICH). The relationship between infection and VTE in ICH patients is unclear. We hypothesized that infection would be associated with subsequent VTE after ICH. We retrospectively studied consecutively admitted spontaneous primary ICH patients from 2009 to 2018 surviving beyond 24 h. The primary predictor variable was infection, diagnosed prior to VTE. The primary outcome was VTE. We used multivariable logistic regression models to estimate the odds ratios and 95% confidence intervals (OR, 95% CI) for VTE risk after infection of any type, after adjusting for ICH score, length of stay and days to deep venous thrombosis (DVT) prophylaxis. Similar analysis was done to estimate the association of infection subtypes, including respiratory and urinary and blood stream infections (BSI) with VTE. There were 414 patients (mean age 65 years, 47% female) that met were analyzed. Infection was diagnosed in 181 (44%) patients. Incident VTE was diagnosed in 36 (9%) patients, largely comprised of DVT (n = 32; 89%). Infection overall was associated with increased risk of subsequent VTE (adjusted OR 4.5, 95% CI 1.6-12.6). Respiratory (adjusted OR 5.7, 95% CI 2.8-11.7) and BSI (adjusted OR 4.0, 95% CI 1.3-11.0) were associated with future VTE. Urinary and other infections were not associated with subsequent VTE. Infections are associated with subsequent risk of VTE among patients with ICH. Further investigation is required to elucidate mechanisms behind this association and to improve VTE prevention after ICH.
Sections du résumé
BACKGROUND
Infection and venous thromboembolism (VTE) are associated with worse outcomes after intracerebral hemorrhage (ICH). The relationship between infection and VTE in ICH patients is unclear. We hypothesized that infection would be associated with subsequent VTE after ICH.
METHODS
We retrospectively studied consecutively admitted spontaneous primary ICH patients from 2009 to 2018 surviving beyond 24 h. The primary predictor variable was infection, diagnosed prior to VTE. The primary outcome was VTE. We used multivariable logistic regression models to estimate the odds ratios and 95% confidence intervals (OR, 95% CI) for VTE risk after infection of any type, after adjusting for ICH score, length of stay and days to deep venous thrombosis (DVT) prophylaxis. Similar analysis was done to estimate the association of infection subtypes, including respiratory and urinary and blood stream infections (BSI) with VTE.
RESULTS
There were 414 patients (mean age 65 years, 47% female) that met were analyzed. Infection was diagnosed in 181 (44%) patients. Incident VTE was diagnosed in 36 (9%) patients, largely comprised of DVT (n = 32; 89%). Infection overall was associated with increased risk of subsequent VTE (adjusted OR 4.5, 95% CI 1.6-12.6). Respiratory (adjusted OR 5.7, 95% CI 2.8-11.7) and BSI (adjusted OR 4.0, 95% CI 1.3-11.0) were associated with future VTE. Urinary and other infections were not associated with subsequent VTE.
CONCLUSIONS
Infections are associated with subsequent risk of VTE among patients with ICH. Further investigation is required to elucidate mechanisms behind this association and to improve VTE prevention after ICH.
Identifiants
pubmed: 32385835
doi: 10.1007/s12028-020-00974-8
pii: 10.1007/s12028-020-00974-8
pmc: PMC7223996
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
85-91Références
Dermatol Ther. 2011 Mar-Apr;24(2):229-39
pubmed: 21410612
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Arch Neurol. 2012 May;69(5):576-81
pubmed: 22782509
Neurocrit Care. 2009;11(1):28-33
pubmed: 19238588
Clin Infect Dis. 2017 Mar 15;64(6):e34-e65
pubmed: 28203777
Thromb Res. 2017 Jan;149:38-44
pubmed: 27886531
Neurosurgery. 2019 Jun 1;84(6):E304-E310
pubmed: 30011018
Crit Care Med. 2018 Mar;46(3):e221-e228
pubmed: 29261568
Stroke. 2014 Dec;45(12):3535-42
pubmed: 25316275
Stroke. 2012 Oct;43(10):2592-7
pubmed: 22858729
J Neurol Sci. 2008 Sep 15;272(1-2):83-6
pubmed: 18555486
Neurocrit Care. 2009;10(1):28-34
pubmed: 18810667
Neurocrit Care. 2016 Oct;25(2):178-84
pubmed: 27350549
Ann Am Thorac Soc. 2016 Dec;13(12):2258-2260
pubmed: 27925784
Adv Ther. 2008 Sep;25(9):831-41
pubmed: 18777016
Semin Thromb Hemost. 2013 Jun;39(4):392-9
pubmed: 23446914
Stroke. 2007 Feb;38(2 Suppl):770-3
pubmed: 17261736
Infect Dis Clin North Am. 2014 Mar;28(1):75-89
pubmed: 24484576
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(2):e428
pubmed: 29318180
Chest. 2015 Nov;148(5):1224-1230
pubmed: 26111103
J Thromb Haemost. 2011 May;9(5):893-8
pubmed: 21324058
Neurosurgery. 2019 Mar 1;84(3):709-716
pubmed: 29788198
Stroke. 2015 Feb;46(2):369-75
pubmed: 25572413
Stroke. 2017 Jun;48(6):1594-1600
pubmed: 28416626
Surgery. 2017 Aug;162(2):325-348
pubmed: 28267992
Semin Thromb Hemost. 2015 Sep;41(6):650-8
pubmed: 26305237
Stroke. 2001 Apr;32(4):891-7
pubmed: 11283388
Open Neurol J. 2014 Apr 04;8:1-6
pubmed: 24847389